Volume: 10 Issue: 2
Year: 2022, Page: 2-8, Doi: https://doi.org/10.47799/pimr.1002.02
Received: Feb. 15, 2022 Accepted: May 20, 2022 Published: May 20, 2022
Introduction: An estimated 9.9 million people fell ill with tuberculosis globally in 2020 with India and China contributing a major percentage to the burden of TB. India is grouped under high TB, high HIV associated TB and MDR TB burden countries and 1.24 lakh fell ill with drug resistant TB out of which 56000 were started on second line treatment in 2020. Annually India accounts for 27% of missing TB cases. Diagnosis: The major forms of drug resistant TB that are of clinical importance are INH monoresistant TB, multidrug resistant TB, pre- XDR TB and XDR TB.WHO approved newer molecular tests for MTB detection and drug susceptibility tests. Treatment: Few newer drugs and few previously used drugs are showing promise when used in combination which have come up in recent years. Bedaquiline based regimens are showing improved cure rates. Conclusion: Guidelines based regimens should be strictly adhered to by both public and private TB case treating physicians.
Keywords: Multi drug resistant tuberculosis (MDR TB), Molecular tests for tuberculosis, Programmatic management of Drug resistant tuberculosis (PMDT), Bedaquiline.
2020. Global tuberculosis report . World Health Organization. https://www.who.int/publications/i/item/9789240013131
2021. Global tuberculosis report . World Health Organization. https://www.who.int/publications/i/item/9789240037021
Oelofse, S, Esmail, A, Diacon, A H, Conradie, F, Olayanju, O & Ngubane, N . 2021. Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts. Int J Tuberc Lung Dis 25(6):453–60.
Chin, D P & Hanson, C L . 2017. Finding the missing tuberculosis patients. The Journal of infectious diseases 216(7):675–683.
Prasad, Jagdish & Ramchandran, Rajani, World health Organization. 2016. Report of the First National Anti TB Drug Resistance Survey. https://tbcindia.gov.in/showfile.php?lid=3315
Subbaraman, R, Nathavitharana, R R, Satyanarayana, S, Pai, M, Thomas, B E & Chadha, V K . 2016. The tuberculosis cascade of care in India’s public sector: a systematic review and meta-analysis. PLoS medicine 13:1002149.
Kilaru, S C, Chenimilla, N P, Syed, U, Momin, K, Kilaru, H & Patil, E . 2019. Role of Xpert MTB/RIF in bronchoalveolar lavage fluid of sputum-scarce, suspected pulmonary TB patients. J Clin Tuberc Other Mycobact Dis 14:7–11.
Linh, N N, Wares, F, Cocozza, A M, Uplekar, M & Raviglione, M . 2020. No universal access to drug-resistant tuberculosis care without engaging all health care providers. Int J Tuberc Lung Dis 24:118–141.
Desai, U & Joshi, J M . 2019. Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair! Lung India 36:3.
Dusthackeer, A, Sekar, G, Chidambaram, S, Kumar, V, Mehta, P & Swaminathan, S . 2015. Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory. Indian J Med Res 142(5):568.
Nguyen, T N, Berre, A L, Bañuls, A L & Nguyen, T V . 2019. Molecular diagnosis of drug-resistant tuberculosis; a literature review. . Frontiers in microbiology. 10:794.
Nguyen, V A, Nguyen, H Q, Vu, T T, Nguyen, N A, Duong, C M, Tran, T H, Nguyen, H V, Dang, D A & Bañuls, A L . 2015. Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay. Clinical Microbiology and Infection. 21:1084–92.
Hoang, T T, Nguyen, N V, Dinh, S N, Nguyen, H B, Cobelens, F, Thwaites, G, Nguyen, H T, Nguyen, A T, Wright, P & Wertheim, H F . 2015. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam. BMC public health 15:1.
Lawson, L, Emenyonu, N, Abdurrahman, S T, Lawson, J O, Uzoewulu, G N, Sogaolu, O M, Ebisike, J N, Parry, C M, Yassin, M A & Cuevas, L E . 2013. Comparison of Mycobacterium tuberculosis drug susceptibility using solid and liquid culture in Nigeria. BMC Research Notes 6(1):1–5.
Lawson, L, Habib, A G, Okobi, M I, Idiong, D, Olajide, I, Emenyonu, N, Onuoha, N, Cuevas, L E & Ogiri, S O . 2010. Pilot study on multidrug resistant tuberculosis in Nigeria. Annals of African medicine 9(3).
Singhal, R, Arora, J, Lal, P, Bhalla, M, Myneeedu, V P & Behera, D . 2012. Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis. The Indian Journal of Medical Research 136(6):1044.
Jeanes, C, Grady, O’ & J . 2016. Diagnosing tuberculosis in the 21st century–Dawn of a genomics revolution? International journal of mycobacteriology 5(4):384–91.
Mäkinen, J, Marttila, H J, Marjamäki, M, Viljanen, M K & Soini, H . 2006. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. Journal of clinical microbiology 44(2):350–352.
Nathavitharana, R R, Hillemann, D, Schumacher, S G, Schlueter, B, Ismail, N, Omar, S V, Sikhondze, W, Havumaki, J, Valli, E, Boehme, C & Denkinger, C M . 2016. Multicenter noninferiority evaluation of Hain GenoType MTBDR plus version 2 and Nipro NTM+ MDRTB line probe assays for detection of rifampicin and isoniazid resistance. Journal of clinical microbiology 54(6):1624–1654.
Castan, P, De Pablo, A, Fernández-Romero, N, Rubio, J M, Cobb, B D, Mingorance, J & Toro, C . 2014. Point-of-care system for detection of Mycobacterium tuberculosis and rifampin resistance in sputum samples. Journal of clinical microbiology 52(2):502–509.
Cabibbe, A M, Walker, T M, Niemann, S & Cirillo, D M . 2018. Whole genome sequencing of Mycobacterium tuberculosis. European Respiratory Journal 52(5).
Jang, J G & Chung, J H . 2020. Diagnosis and treatment of multidrug-resistant tuberculosis. Yeungnam University Journal of Medicine 37(4):277.
Sun, F, Li, Y, Chen, Y, Guan, W, Jiang, X, Wang, X, Ren, P, Li, J, Shi, J, He, G & Wu, M . 2019. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment. outcomes: a prospective cohort study. European Respiratory Journal 53(3).
Pontali, E, Raviglione, M C & Migliori, G B . 2019. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. European Respiratory Review 28(152).
2019. WHO consolidated guidelines on drug-resistant tuberculosis treatment. World Health Organization. https://apps.who.int/iris/handle/10665/311389
2021. National TB elimination programme central division, Ministry of Health & Family welfare Government of India. New Delhi:
Nunn, A J, Phillips, P P, Meredith, S K, Chiang, C Y, Conradie, F, Dalai, D, Van Deun, A, Dat, P T, Lan, N, Master, I & Mebrahtu, T . 2019. A trial of a shorter regimen for rifampin-resistant tuberculosis. New England Journal of Medicine 380(13):1201–1214.
Padayatchi, N, Bionghi, N, Osman, F, Naidu, N, Ndjeka, N, Master, I, Brust, J C, Naidoo, K & Ramjee, A . 2020. Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid. The International Journal of Tuberculosis and Lung Disease 24:1024–1055.
Conradie, F, Diacon, A H, Ngubane, N, Howell, P, Everitt, D, Crook, A M, Mendel, C M, Egizi, E, Moreira, J, Timm, J, Mchugh, T D, Wills, G H, Bateson, A, Hunt, R, Van Niekerk, C, Li, M, Olugbosi, M, Spigelman, M, Nix, -Tb Trial & Team, . 2020. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med 382(10):6955640.
Xu, J, Li, S Y, Almeida, D V, Tasneen, R, Barnes-Boyle, K, Converse, P J, Upton, A M, Mdluli, K, Fotouhin, & Nuermberger, E L . 2019. Contribution of pretomanid to novel regimens containingbedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis. Antimicrobial agents and chemotherapy 63(5):21–40.
Akkerman, O W, Tiberi, S & Alffenaar, J W . 2021. Shortening MDR-TB treatment: is treating more patients with fewer drugs better. The International Journal of Tuberculosis and Lung Disease 25:419–439.
Wrohan, I, Nguyen, T A, Nguyen, V N, Nguyen, B H, Hoang, T T, Nguyen, P C, Velen, K, Marks, G B & Fox, G J . 2022. Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study. BMC Infectious Diseases 22(1):1–2.
Chenimilla NP, Pittala P, Madire R. Review on Drug Resistant Tuberculosis. Perspectives in Medical Research. 2022;10(2):2-8 DOI: 10.47799/pimr.1002.02